Q13 Continuous Manufacturing of Drug Substances and Drug Products(Final)-2323/03/01

关于公开征求《间充质干细胞防治移植物抗宿主病临床试验技术指导原则（征求意见稿）》意见的通知-2023/9/12

Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations-2025/1/7

Page: Linguistic review - Human-2025/2/10

Document: PRAC recommendations on signals adopted at the 10-13 February 2025 meeting-2025/3/17

Page: Variations requiring assessment (veterinary medicines)-2025/4/16

Document: New product information wording: extracts from PRAC recommendations on signals adopted at the 5-8 May 2025 PRAC-2025/6/2

Document: Recommendations of the Executive Steering Group on Shortages and Safety of Medicinal Products to address anti-D immunoglobulin supply chain vulnerabilities-2025/7/4

Document: Medicine shortage communication (MSC): Zypadhera (olanzapine pamoate monohydrate <210 mg / 300 mg / 405 mg> powder and solvent for prolonged release suspension for injection)-2024/8/7

Document: Members of the Coordinating group of European network of paediatric research at the European Medicines Agency (Enpr-EMA)-2025/9/24